197 related articles for article (PubMed ID: 32195970)
1. Over expression of CDK4 and MDM2 in a patient with recurrent ALK-negative mediastinal inflammatory myofibroblastic tumor: A case report.
Hou TC; Wu PS; Huang WY; Yang YT; Tan KT; Liu SH; Chen YJ; Chen SJ; Su YW
Medicine (Baltimore); 2020 Mar; 99(12):e19577. PubMed ID: 32195970
[TBL] [Abstract][Full Text] [Related]
2. p53 Mutation and MDM2 amplification in inflammatory myofibroblastic tumours.
Yamamoto H; Oda Y; Saito T; Sakamoto A; Miyajima K; Tamiya S; Tsuneyoshi M
Histopathology; 2003 May; 42(5):431-9. PubMed ID: 12713619
[TBL] [Abstract][Full Text] [Related]
3. FN1: a novel fusion partner of ALK in an inflammatory myofibroblastic tumor.
Ouchi K; Miyachi M; Tsuma Y; Tsuchiya K; Iehara T; Konishi E; Yanagisawa A; Hosoi H
Pediatr Blood Cancer; 2015 May; 62(5):909-11. PubMed ID: 25682942
[TBL] [Abstract][Full Text] [Related]
4. Oral inflammatory myofibroblastic tumor demonstrating ALK, p53, MDM2, CDK4, pRb, and Ki-67 immunoreactivity in an elderly patient.
Brooks JK; Nikitakis NG; Frankel BF; Papadimitriou JC; Sauk JJ
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Jun; 99(6):716-26. PubMed ID: 15897859
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall.
Kerr DA; Thompson LDR; Tafe LJ; Jo VY; Neyaz A; Divakar P; Paydarfar JA; Pastel DA; Shirai K; John I; Seethala RR; Salgado CM; Deshpande V; Bridge JA; Kashofer K; Brčić I; Linos K
Am J Surg Pathol; 2021 Dec; 45(12):1707-1719. PubMed ID: 34001695
[TBL] [Abstract][Full Text] [Related]
7. An inflammatory myofibroblastic tumour of the breast with ALK overexpression.
Zhou Y; Zhu J; Zhang Y; Jiang J; Jia M
BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23386486
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory myofibroblastic tumor of the central nervous system: clinicopathologic analysis of 10 cases.
Jeon YK; Chang KH; Suh YL; Jung HW; Park SH
J Neuropathol Exp Neurol; 2005 Mar; 64(3):254-9. PubMed ID: 15804057
[TBL] [Abstract][Full Text] [Related]
9. [Inflammatory myofibroblastic tumor].
Leuschner I
Pathologe; 2010 Mar; 31(2):106-8. PubMed ID: 20063099
[TBL] [Abstract][Full Text] [Related]
10. [Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features: a clinicopathological analysis of five cases].
Si HP; Wang Z; Fan QH; Zhang YF; Yang DQ; Zhang ZH; Gong QX
Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):282-287. PubMed ID: 30955263
[No Abstract] [Full Text] [Related]
11. Inflammatory myofibroblastic tumor of bone harboring an ALK gene amplification.
Wang K; Guo R; Siegal GP; Wei S
Pathol Res Pract; 2019 Sep; 215(9):152535. PubMed ID: 31326196
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic lymphoma kinase-negative pulmonary inflammatory myofibroblastic tumor with multiple metastases and its treatment by Apatinib: A case report.
Liu Q; Wei J; Liu X; Wang J
Medicine (Baltimore); 2019 Dec; 98(52):e18414. PubMed ID: 31876714
[TBL] [Abstract][Full Text] [Related]
13. Myofibroblastic tumours: neoplasias with divergent behaviour. Ultrastructural and flow cytometric analysis.
Biselli R; Boldrini R; Ferlini C; Boglino C; Inserra A; Bosman C
Pathol Res Pract; 1999; 195(9):619-32. PubMed ID: 10507082
[TBL] [Abstract][Full Text] [Related]
14. Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall.
Yorita K; Togashi Y; Nakagawa H; Miyazaki K; Sakata S; Baba S; Takeuchi K; Hayashi Y; Murakami I; Kuroda N; Oda Y; Kohashi K; Yamada Y; Kiyozawa D; Michal M; Michal M
Pathol Int; 2019 Jun; 69(6):366-371. PubMed ID: 31215130
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.
Hisaoka M; Shimajiri S; Matsuki Y; Meis-Kindblom JM; Kindblom LG; Li XQ; Wang J; Hashimoto H
Pathol Int; 2003 Jun; 53(6):376-81. PubMed ID: 12787312
[TBL] [Abstract][Full Text] [Related]
16. Expression of hypoxia-related markers in inflammatory myofibroblastic tumors of the head and neck.
Wang KR; Jiang T; Wu TT; Zhou SH; Yao HT; Wang QY; Lu ZJ
World J Surg Oncol; 2013 Nov; 11():294. PubMed ID: 24245510
[TBL] [Abstract][Full Text] [Related]
17. Uterine Inflammatory Myofibroblastic Neoplasms With Aggressive Behavior, Including an Epithelioid Inflammatory Myofibroblastic Sarcoma: A Clinicopathologic Study of 9 Cases.
Collins K; Ramalingam P; Euscher ED; Reques Llanos A; García A; Malpica A
Am J Surg Pathol; 2022 Jan; 46(1):105-117. PubMed ID: 34138797
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features.
Devaney KO; Lafeir DJ; Triantafyllou A; Mendenhall WM; Woolgar JA; Rinaldo A; Ferlito A
Eur Arch Otorhinolaryngol; 2012 Dec; 269(12):2461-5. PubMed ID: 22588194
[TBL] [Abstract][Full Text] [Related]
19. An isolated inflammatory myofibroblastic tumor of adrenal gland.
Al Sannaa G; Wimmer JL; Ayala AG; Ro JY
Ann Diagn Pathol; 2016 Dec; 25():33-36. PubMed ID: 27806843
[TBL] [Abstract][Full Text] [Related]
20. ALK-negative lung inflammatory myofibroblastic tumor in a young adult: A case report and literature review of molecular alterations.
Debonis SA; Bongiovanni A; Pieri F; Fausti V; De Vita A; Riva N; Gurrieri L; Vanni S; Diano D; Mercatali L; Ibrahim T
Medicine (Baltimore); 2021 May; 100(20):e25972. PubMed ID: 34011083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
